1.The Endoscopic Polypectomy in a Case of Duodenal Lipoma.
Sang Pyo KOOK ; Sang Woo LEE ; Ho Sang RYU ; Jin Hai HYUN
Korean Journal of Gastrointestinal Endoscopy 1984;4(1):55-58
The duodenal lipoma is infrequent and few reports deseribed its endoscopic features, We recently encountered one case of duodenal lipoma which was large polypoid one in the descending portion of the duodenum. The patient had been suffred from epigastric dull pain and bloating sensatio for 5 months. We did endoscopic polypectomy of the lipoma successfully.
Duodenum
;
Humans
;
Lipoma*
2.A case of malignant external otitis using scintigraphic study.
Chun Keun PARK ; Sang Hyeon KIM ; Eun Pyo PARK ; Seong Kook PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(6):925-929
No abstract available.
Otitis Externa*
3.Inhibition of Lung Inflammation by Acanthopanax divaricatus var. Albeofructus and Its Constituents.
Ju Hee LEE ; Ya Nan SUN ; Young Ho KIM ; Sang Kook LEE ; Hyun Pyo KIM
Biomolecules & Therapeutics 2016;24(1):67-74
In order to find potential therapeutic agents on lung inflammatory conditions, the extracts of Acanthopanax divaricatus var. albeofructus were prepared and its constituents were isolated. They include lignans such as (+)-syringaresinol (1), acanthoside B (2), salvadoraside (3) and acanthoside D (4), lariciresinol-9-O-beta-D-glucopyranoside (5) and phenylpropanoids such as 4-[(1E)-3-methoxy-1-propenyl]phenol (6), coniferin (7), and methyl caffeate (8). The extracts and several constituents such as compound 1, 6 and 8 inhibited the production of inflammatory markers, IL-6 and nitric oxide, from IL-1beta-treated lung epithelial cells and lipopolysaccharide (LPS)-treated alveolar macrophages. Furthermore, the extracts and compound 4 significantly inhibited lung inflammation in lipolysaccharide-treated acute lung injury in mice by oral administration. Thus it is suggested that A. divaricatus var. albeofructus and its several constituents may be effective against lung inflammation.
Eleutherococcus*
;
Acute Lung Injury
;
Administration, Oral
;
Animals
;
Epithelial Cells
;
Interleukin-6
;
Lignans
;
Lung*
;
Macrophages
;
Macrophages, Alveolar
;
Mice
;
Nitric Oxide
;
Pneumonia*
4.Inhibition of Proinflammatory Cytokine Generation in Lung Inflammation by the Leaves of Perilla frutescens and Its Constituents.
Hun Jai LIM ; Kyeong Wan WOO ; Kang Ro LEE ; Sang Kook LEE ; Hyun Pyo KIM
Biomolecules & Therapeutics 2014;22(1):62-67
This study was designed to find some potential natural products and/or constituents inhibiting proinflammatory cytokine generation in lung inflammation, since cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) are pivotal for provoking airway inflammation. In our preliminary screening procedure, the 70% ethanol extract of the leaves of Perilla frutescens (PFE) was found to clearly inhibit TNF-alpha production in the lung at 100 mg/kg, after intranasal lipopolysaccharide treatment of mice. Based on this result, ten constituents including phenylpropanoids (allyltetramethoxybenzene, caffeic acid, dillapiole, elemicin, myristicin, nothoapiole, rosmarinic acid methyl ester, rosmarinic acid) and monoterpenes (perilla aldehyde and perilla ketone) were successfully isolated from the extract. Among them, elemicin and myristicin were found for the first time to concentration-dependently inhibit IL-1beta-treated IL-6 production from lung alveolar epithelial cells (A549) at concentrations of 10-100 microM. These findings suggest that the phenylpropanoids including elemicin and myristicin have the potential to be new inhibitory agents against lung inflammation and they may contribute, at least in part, to the inhibitory activity of PFE on the lung inflammatory response.
Animals
;
Biological Products
;
Bronchitis
;
Cytokines
;
Epithelial Cells
;
Ethanol
;
Inflammation
;
Interleukin-6
;
Lung
;
Mass Screening
;
Mice
;
Monoterpenes
;
Perilla
;
Perilla frutescens*
;
Pneumonia*
;
Tumor Necrosis Factor-alpha
5.Inhibition of Proinflammatory Cytokine Generation in Lung Inflammation by the Leaves of Perilla frutescens and Its Constituents.
Hun Jai LIM ; Kyeong Wan WOO ; Kang Ro LEE ; Sang Kook LEE ; Hyun Pyo KIM
Biomolecules & Therapeutics 2014;22(1):62-67
This study was designed to find some potential natural products and/or constituents inhibiting proinflammatory cytokine generation in lung inflammation, since cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) are pivotal for provoking airway inflammation. In our preliminary screening procedure, the 70% ethanol extract of the leaves of Perilla frutescens (PFE) was found to clearly inhibit TNF-alpha production in the lung at 100 mg/kg, after intranasal lipopolysaccharide treatment of mice. Based on this result, ten constituents including phenylpropanoids (allyltetramethoxybenzene, caffeic acid, dillapiole, elemicin, myristicin, nothoapiole, rosmarinic acid methyl ester, rosmarinic acid) and monoterpenes (perilla aldehyde and perilla ketone) were successfully isolated from the extract. Among them, elemicin and myristicin were found for the first time to concentration-dependently inhibit IL-1beta-treated IL-6 production from lung alveolar epithelial cells (A549) at concentrations of 10-100 microM. These findings suggest that the phenylpropanoids including elemicin and myristicin have the potential to be new inhibitory agents against lung inflammation and they may contribute, at least in part, to the inhibitory activity of PFE on the lung inflammatory response.
Animals
;
Biological Products
;
Bronchitis
;
Cytokines
;
Epithelial Cells
;
Ethanol
;
Inflammation
;
Interleukin-6
;
Lung
;
Mass Screening
;
Mice
;
Monoterpenes
;
Perilla
;
Perilla frutescens*
;
Pneumonia*
;
Tumor Necrosis Factor-alpha
6.A clinical analysis of laryngotracheal stenosis.
Jae Wook EOM ; Seong Kook PARK ; Eun Pyo PARK ; Bong Whan OH ; Jae Wan LEE ; Sang Cheol LEE ; Chun Keun PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(4):785-794
No abstract available.
Constriction, Pathologic*
7.Endobronchial Closure of Postoperative Bronchopleural Fistula Using Vascular Occluding Coils.
Kook Joo NA ; Byung Pyo KIM ; Seong Beom HONG ; Yong Sun CHOI ; Sang Hyung KIM ; Byung Hee AHN
The Korean Journal of Thoracic and Cardiovascular Surgery 2005;38(1):72-75
A bronchopleural fistula after pulmonary resection is still showing high mortality and morbidity despite of advancing of treatment. Several treatment options have been developed including surgical treatment. In 1990, endobronchial closure using vascular occluding coils was introduced. These coils can occlude a bronchial air-leakage by mechanical obstruction as well as inducing fibrosis. We report, herein, the experience using a vascular occluding coils in treating postoperative bronchopleural fistula.
Embolization, Therapeutic
;
Empyema
;
Fibrosis
;
Fistula*
;
Mortality
8.A Case of Pulmonary Inflammatory Myofibroblastic Tumor.
Kook Joo NA ; Ung YU ; Sung Bum HONG ; Yong Sun CHOI ; Byong Pyo KIM ; Sang Hyung KIM ; Byong Hee AHN
The Korean Journal of Thoracic and Cardiovascular Surgery 2004;37(1):102-104
Inflammatory myofibroblastoma is a solid tumor, occurring mainly to children and young adults, and occupying 0.7% of total isolated pulmonary nodules. Since 1973, several cases about inflammatory myofibroblastoma have been reported. Firstly, this tumor was found in lungs. Then, tumors have been founded and reported in mesentery or cardioesophageal region. Histologically, this tumor can be classified as a benign tumor. However, since this tumor has two characteristics showing malignancy, that is, local invasion and recurrence, malignancy can not be completely excluded. Recently, a patient with pulmonary inflammatory myofibroblastoma underwent surgical resection without any signs or symptoms of recurrence.
Child
;
Humans
;
Lung
;
Lung Neoplasms
;
Mesentery
;
Myofibroblasts*
;
Neoplasms, Muscle Tissue
;
Recurrence
;
Young Adult
9.Total Arterial Revascularization Using Y-composite Graft for Isolated Left Main Coronary Artery Disease.
Byong Hee AHN ; Ung YU ; Jun Kyung CHUN ; Sang Wan RYU ; Yong Sun CHOI ; Byong Pyo KIM ; Sung Bum HONG ; Min Seon BUM ; Kook Ju NA ; Myung Ho JUNG ; Sang Hyung KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2004;37(1):35-42
BACKGROUND: For the treatment of isolated left main coronary artery disease, twelve arterial revascularizations with Y-composite grafts using left internal thoracic artery and radial artery or right gastroepiploic artery were performed. This study was performed to investigate whether Y-composite graft can satisfy the blood flow required to make myocardium act properly or not. Borderline stenotic lesions on the left main coronary artery, which are very prone to remodel the bypassed vessels due to competitive flows, were also considered. MATERIAL AND METHOD: Among 247 patients who underwent coronary artery bypass grafting from March 2000 to April 2003, 12 patients (4.7%) who had received total arterial revascularizations for the isolated left main coronary artery disease were studied retrospectively. RESULT: Left anterior descending arteries were bypassed with left internal thoracic artery by off-pump technique in all patients, however, 2 cases of left obtuse marginal branches were bypassed under on-pump beating heart. Except for one patient, who did not have an obtuse marginal branch more than 1 mm in diameter, 11 patients had gone through complete arterial revascularizaions by use of the Y shape arterial graft. Among five patients who had less than 75% stenosis, one patient showed string sign on left internal thoracic artery grafted to left anterior descending artery. However, two grafts to obtuse marginal branches were completely obstructed and one showed slender sign. There were no graft-dominant flow in patients with stenotic lesion less than 75%. On the contrary to the result of patients with stenotic lesions less than 75%, all the patients with stenotic lesions more than 90% showed graft-dominant blood flow. CONCLUSION: In conclusion, it is assumed that, when stenotic lesions are over 90%, coronary artery bypass grafting with an Y shape arterial graft could possibly give enough help to the obstructed coronary arteries in blood supplying to myocardium, which needs massive quantity of blood to act well. However, when patients have borderline stenoses, through scrupulous examinations, more prudent and flexible decisions are required in choosing the treatment methods, such as, direct anastomosis of vein or artery to aorta, or adding supplementary treatment methods like percutaneous coronary intervention, rather than choosing a fixed treatment methods.
Aorta
;
Arteries
;
Constriction, Pathologic
;
Coronary Artery Bypass
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Gastroepiploic Artery
;
Heart
;
Humans
;
Mammary Arteries
;
Myocardium
;
Percutaneous Coronary Intervention
;
Radial Artery
;
Retrospective Studies
;
Transplants*
;
Veins
10.Early and Mid-term Results of Operation for Infective Endocarditis on Mitral Valve.
Byong Hee AHN ; Joon Kyung CHUN ; Ung YU ; Sang Wan RYU ; Yong Sun CHOI ; Byong Pyo KIM ; Sung Bum HONG ; Min Sun BUM ; Kook Ju NA ; Jong Chun PARK ; Sang Hyung KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2004;37(1):27-34
BACKGROUND: Infective endocarditis shows higher operative morbidity and mortality rates than other cardiac diseases. The vast majority of studies on infective endocarditis have been made on aortic endocarditis, with little attention having been paid to infective endocarditis on the mitral valve. This study attempts to investigate the clinical aspects and operative results of infective endocarditis on the mitral valve. METERIAL AND METHOD: The subjects of this study consist of 23 patients who underwent operations for infective endocariditis on the mitral valve from June 1995 to May 2003. Among them, 2 patients suffered from prosthetic valvular endocarditis and the other 21 from native valvular endocarditis. The subjects were evenly distributed age-wise with an average age of 44.8+/-15.7 (11~66) years. Emergency operations were performed on seventeen patients (73.9%) due to large vegetation or instable hemodynamic status. In preoperative examinations, twelve patients exhibited congestive heart failure, four patients renal failure, two patients spleen and renal infarction, and two patients temporary neurological defects, while one patient had a brain abscess. Based on the NYHA functional classification, seven patients were determined to be at Grade II, 9 patients at Grade III, and 6 patients at Grade IV. Vegetations were detected in 20 patients while mitral regurgitation was dominant in 19 patients with 4 patients showing up as mitral stenosis dominant on the preoperative echocardiogram. Blood cultures for causative organisms were performed on all patients, and positive results were obtained from ten patients, with five cases of Streptococcus viridance, two cases of methicillin-sensitive Staphylococcus aureus, and one case each of Corynebacterium, Haemophillis, and Gernella. Operations were decided according to the AA/AHA guidelines (1988). The mean follow-up period was 27.6+/-23.3 (1~97) months. RESULT: Mitral valve replacements were performed on 13 patients, with mechanical valves being used on 9 patients and tissue valves on the other 4. Several kinds of mitral valve repair or mitral valvuloplasty were carried out on the remaining 10 patients. Associated procedures included six aortic valve replacements, two tricuspid annuloplasty, one modified Maze operation, and one direct closure of a ventricular septal defect. Postoperative complications included two cases of bleeding and one case each of mediastinitis, low cardiac output syndrome, and pneumonia. There were no cases of early deaths, or death within 30 days following the operation. No patient died in the hospital or experienced valve related complications. One patient, however, underwent mitral valvuloplasty 3 months after the operation. Another patient died from intra-cranial hemorrhage in the 31st month after the operation. Therefore, the valve-related death rate was 4.3%, and the valve-related complication rate 8.6% on mid-term follow-up. 1, 3-, and 5-year valve- related event free rates were 90.8%, 79.5%, and 79.5%, respectively, while 1, follow-up. 1, 3-, and 5-year valve- related event free rates were 90.8%, 79.5%, and 79.5%, respectively, while 1, 3-, and 5-year survival rates were 100%, 88.8%, and 88.8%, respectively. CONCLUSION: The findings suggest that a complete removal of infected tissues is essential in the operative treatment of infectious endocarditis of the mitral valve. It is also suggested that when infected tissues are completely removed, neither type of material nor method of operation has a significant effect on the operation result. The postoperative results also suggest the need for a close follow-up observation of the patients suspected of having brain damage, which is caused by preoperative blood contamination or emboli from vegetation, for a possible cerebral vascular injury such as mycotic aneurysm.
Aneurysm, Infected
;
Aortic Valve
;
Brain
;
Brain Abscess
;
Cardiac Output, Low
;
Classification
;
Corynebacterium
;
Emergencies
;
Endocarditis*
;
Follow-Up Studies
;
Heart Diseases
;
Heart Failure
;
Heart Septal Defects, Ventricular
;
Hemodynamics
;
Hemorrhage
;
Humans
;
Infarction
;
Mediastinitis
;
Methods
;
Mitral Valve Insufficiency
;
Mitral Valve Stenosis
;
Mitral Valve*
;
Mortality
;
Pneumonia
;
Postoperative Complications
;
Renal Insufficiency
;
Spleen
;
Staphylococcus aureus
;
Streptococcus
;
Survival Rate
;
Vascular System Injuries